Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
Santamato
Andrea
A
Ianieri
Giancarlo
G
Ranieri
Maurizio
M
Megna
Marisa
M
Panza
Francesco
F
Fiore
Pietro
P
Megna
Gianfranco
G
D000368:Aged; D000369:Aged, 80 and over; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage*; D010300:Parkinson Disease / Q000150:complications*; D010306:Parotid Gland; D012798:Sialorrhea / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A